Karim Hamaoui

Dr. Karim Hamaoui


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Journal of Surgical Research
Verified
Journal Article
Closed access
KHKarim Hamaoui
Karim Hamaoui
SGSally Gowers
Sally Gowers
BSBynvant Sandhu
Bynvant Sandhu
NVNatalie Vallant
Natalie Vallant
TCTerry Cook
Terry Cook
VPVassilios Papalois
Vassilios Papalois

10 July 2019 in Current Diabetes Reports
Verified
Journal Article
Open access
PDF file
KHKarim Hamaoui
Karim Hamaoui
Vassilios PapaloisVassilios Papalois
Vassilios Papalois
Purpose of Review Pancreas transplantation enables complete patient independence from exogenous insulin administration and increases both patient survival and quality of life. Despite this, there has been a decline in pancreas transplantation for the past 20 years, influenced by changing donor demographics with more high-risk extended criteria (ECD) and donation after cardiac death (DCD) donors. This review discusses whether the advent of machine perfusion (MP), if extended to the pancreas, can increase the pool of suitable donor organs. Recent Findings Hypothermic and normothermic MP, as forms of preservation deemed superior to cold storage for high-risk kidney and liver donor organs, have opened the avenue for translation of this work into the pancreas. Recent experimental models of porcine and human ex-vivo pancreatic MP are promising. Applications of MP to the pancreas however need refinement—focusing on perfusion protocols and viability assessment tools. Summary Emerging research shows pancreatic MP can potentially offer superior preservation capacity, the ability to both resuscitate and manipulate organs, and assess functional and metabolic organ viability. The future of MP will lie in organ assessment and resuscitation after retrieval, where ultimately organs initially considered high risk and unsuitable for transplantation will be optimised and transformed, making them then available for clinical use, thus increasing the pool of suitably viable pancreata for transplantation.


1 February 2017 in Journal of Surgical Research
Verified
Journal Article
Closed access
KHKarim Hamaoui
Karim Hamaoui
AAAdeel Aftab
Adeel Aftab
SGSally Gowers
Sally Gowers
MBMartyn Boutelle
Martyn Boutelle
TCTerry Cook
Terry Cook
VPVassilios Papalois
Vassilios Papalois

11 December 2023 in European Surgical Research
Verified
Journal Article
Open access
PDF file
KHKarim Hamaoui
Karim Hamaoui
SGSally Gowers
Sally Gowers
MBMartyn Boutelle
Martyn Boutelle
VPVassilios Papalois
Vassilios Papalois
The perpetual organ shortage crisis worldwide has meant a paradigm shift in global thinking with subsequent expansion of the accepted criteria for an organ donor to meet the demand. Robust pre-transplant organ viability assessment is the next great challenge in the field of transplantation today. Organ preservation in the nature of static cold storage has reached its limits, and machine perfusion both cold and warm offers theoretically superior preservation and the potential to assess organs. Microdialysis is a novel technique with proven ability to allow remote assessment of tissue biochemistry and metabolism. It has been used in various pre-clinical and clinical models of abdominal organ preservation and transplantation. This review focuses on the use of microdialysis in the assessment of the kidney, liver, and pancreas, and where this novel technology is heading in the context of the assessing organ viability prior to and after transplantation.

Verified
Journal Article
Open access
PDF file
NVNatalie Vallant
Natalie Vallant
BSBynvant Sandhu
Bynvant Sandhu
KHKarim Hamaoui
Karim Hamaoui
MPMaria Prendecki
Maria Prendecki
CPCharles Pusey
Charles Pusey
Vassilios PapaloisVassilios Papalois
Vassilios Papalois
Mesenchymal Stromal Cells (MSC) have been shown to exhibit immuno-modulatory and regenerative properties at sites of inflammation. In solid organ transplantation (SOT), administration of MSCs might lead to an alleviation of ischemia-reperfusion injury and a reduction of rejection episodes. Previous reports have suggested ‘MSC-preconditioning’ of macrophages to be partly responsible for the beneficial effects. Whether this results from direct cell-cell interactions (e.g., MSC trans-differentiation at sites of damage), or from paracrine mechanisms, remains unclear. Immunosuppressive capacities of MSCs from donors of different age and from genetically modified donor animals, often used for in-vivo experiments, have so far not been investigated. We conducted an in vitro study to compare paracrine effects of supernatants from MSCs extracted from young and old wild-type Wystar-Kyoto rats (WKY-wt), as well as young and old WKY donor rats positive for the expression of green fluorescent protein (WKY-GFP), on bone marrow derived macrophages (BMDM). Expression levels of Mannose receptor 1 (Mrc-1), Tumor necrosis factor α (TNFα), inducible NO synthase (iNos) and Interleukin-10 (IL-10) in BMDMs after treatment with different MSC supernatants were compared by performance of quantitative PCR. We observed different expression patterns of inflammatory markers within BMDMs, depending on age and genotype of origin for MSC supernatants. This must be taken into consideration for preclinical and clinical studies, for which MSCs will be used to treat transplant patients, aiming to mitigate inflammatory and allo-responses.